2006 NF Consortium for NF1, NF2 and Schwannomatosis

2006 NF1、NF2 和神经鞘瘤病联盟

• 批准号: 7162767
• 负责人: VIJAYA RAMESH
• 金额: $ 3.05万
• 依托单位: CHILDREN'S TUMOR FOUNDATION
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-07-15 至 2007-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7162767
• 关键词: meeting /conference /symposium; neurofibromatosis; meeting /conference /symposium; neurofibromatosis

DESCRIPTION (provided by applicant): This application requests funding support for the 2006 annual meeting of the Children's Tumor Foundation International Consortium for the Molecular and Cell Biology of NF1, NF2 and Schwannomatosis. The Meeting will be held June 4-7, 2006, at the Hotel Jerome in Aspen, Colorado. This annual meeting has had a fruitful history since its inception in 1985, and it plays a lynchpin role as the premier annual gathering of researchers and clinicians in the NF community. The meeting is a forum for research information exchange and discussion for researchers from around the world, and has traditionally fostered collaboration, consensus building, and advances in translational research culminating in clinical trials. This is a time of tremendous advances in NF research on many fronts from basic through clinical, and this is reflected in the theme of the 2006 meeting - "Progress: From Bench to Bedside". Five individual sessions will take the Consortium from molecular mechanisms of NF through translational models to clinical therapies. Speakers will include both junior and senior researchers. In keeping with the bench to bedside theme, for the first time select sessions will include a few words from a patient advocate whose life is affected by NF. Each session will also include a keynote address by a leading investigator from outside of NF research to open up broad ranging discussions. Competitive travel awards will bring young investigators for oral presentations, and 2 poster sessions will allow investigators to present their work to the NF community. In 2006 we are taking two new approaches in order to increase the visibility of this meeting and of the state of NF research. Firstly to increase industry awareness of NF we will seek fiscal sponsorship for this meeting from a large number of pharmaceutical companies. Incentive sponsorships will be offered at diamond, platinum, gold and silver levels. Secondly, the co-chairs and the Foundation will work together to seek publication of a Consortium Report in a peer-reviewed journal. This will promote to the research community at large the status of NF research, the link with other cancers and neurological disorders and the key barriers to be addressed.

描述（由申请人提供）：本申请要求为NF1，NF2和Schwannomatisoise的分子和细胞生物学国际肿瘤基金会2006年会议提供资金支持。 会议将于2006年6月4日至7日在科罗拉多州阿斯彭的杰罗姆酒店举行。 自1985年成立以来，这次年度会议一直具有富有成果的历史，并且扮演着NF社区中研究人员和临床医生的主要年度聚会。 该会议是一个针对来自世界各地的研究人员进行研究信息交流和讨论的论坛，传统上促进了合作，共识建立以及转化研究的进步，最终在临床试验中达到最终形式。 这是从基本到临床的许多方面的NF研究取得巨大进步的时期，这反映在2006年会议的主题中 - “进度：从长凳到床边”。 五个单独的课程将通过转化模型从NF的分子机制来纳入临床疗法。 演讲者将包括初级和高级研究人员。 为了与卧床主题保持一致，首次选择会议将包括一个患者倡导者的几个单词，其生活受到NF的影响。 每个会议还将包括NF研究外部领先的调查员的主题演讲，以开展广泛的讨论。 竞争性旅行奖将为年轻的调查员提供口头演讲，两次海报会议将使调查人员能够向NF社区介绍其作品。 2006年，我们采用了两种新方法，以提高这次会议和NF研究状态的可见性。 首先，为了提高行业对NF的认识，我们将向许多制药公司的会议寻求财政赞助。 奖励赞助将在钻石，白金，黄金和银色水平提供。 其次，共同主席和基金会将共同努力，在同行评审期刊中宣布一份财团报告。 这将促进NF研究状况，与其他癌症和神经系统疾病的联系以及要解决的关键障碍的联系。